Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 115 of 200 · By data quality, then INN

  1. zanamivir

    DECTOVA

    INHALATION FDA: approved · EMA: approved

    J05AH01

  2. zavegepant hydrochloride

    ZAVZPRET

    NASAL FDA: approved

  3. zenocutuzumab-zbco

    BIZENGRI

    SOLUTION FDA: approved

  4. ziconotide acetate

    PRIALT

    INTRATHECAL FDA: approved

  5. zilucoplan sodium

    ZILBRYSQ

    SUBCUTANEOUS FDA: approved · PMDA: approved

  6. zinc chloride

    ZINC CHLORIDE

    INJECTION FDA: approved

  7. ziprasidone hydrochloride

    ZIPRASIDONE HYDROCHLORIDE

    ORAL FDA: approved

  8. ziprasidone mesylate

    ZIPRASIDONE MESYLATE

    INTRAMUSCULAR FDA: approved

  9. ziv-aflibercept

    ZALTRAP

    INJECTION FDA: approved

  10. zolbetuximab-clzb

    VYLOY

    INJECTION FDA: approved

  11. zoliflodacin

    NUZOLVENCE

    ORAL FDA: approved

  12. zongertinib

    HERNEXEOS

    ORAL FDA: approved · NMPA: clinical trials

  13. zonisamide

    ZONEGRAN Amdipharm Mercury (Australia) Pty Limited

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    N03AX15

  14. zuranolone

    ZURZUVAE

    ORAL FDA: approved · EMA: approved

    N06A

  15. 1-13c-caprylic acid

    GASTROMOTAL

    EMA: application withdrawn

  16. 13c-urea

    HELICOBACTER TEST INFAI

    EMA: approved

    V04CX

  17. 5-aminolevulinic acid hydrochloride

    AMELUZ

    EMA: approved

    L01XD04

  18. a/vietnam/1194/2004

    AFLUNOV

    EMA: application withdrawn

  19. abetimus

    RIQUENT

    EMA: application withdrawn

  20. abicipar pegol

    RAYOQTA

    EMA: application withdrawn

    S01LA

  21. abiraterone

    ABIRATERONE DR.REDDY''S Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    L02BX03

  22. aclidinium

    BRETARIS GENUAIR A.Menarini Australia Pty Limited

    EMA: approved · TGA: approved

    R03AL05

  23. acoramidis

    BEYONTTRA

    EMA: approved

    C01EB25

  24. adalimumab

    ABRILADA Pfizer Australia Pty Ltd

    FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L04AB04

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.